Pharmaceutical formulation
The present invention relates to a pharmaceutical formulation comprising an active pharmaceutical ingredient (3S, 3S, 3S ', 3S', 3S ', 3S', 3S ', 3S', 3S ', 3S', 3S ', 3S' The present invention relates to a pharmaceutical composition comprising a pha...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a pharmaceutical formulation comprising an active pharmaceutical ingredient (3S, 3S, 3S ', 3S', 3S ', 3S', 3S ', 3S', 3S ', 3S', 3S ', 3S' The present invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable salt of (4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl) thio) pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro [4.5] decane-4-amine, or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient, the pharmaceutical formulation is made by a process including wet granulation, direct compression or in particular rolling.
本发明涉及一种药物配制品以及本文披露的相关的本发明的方面,该药物配制品包含活性药物成分(3S,4S)-8-(6-氨基-5-((2-氨基-3-氯吡啶-4-基)硫代)吡嗪-2-基)-3-甲基-2-氧杂-8-氮杂螺[4.5]癸烷-4-胺或其药学上可接受的盐和至少一种药学上可接受的赋形剂,其中特别地,该药物配制品通过包括湿法造粒、直接压缩或尤其是辊压的工艺制成。 |
---|